- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Overgangscellekræft in Japan
I alt 1680 resultater
-
BayerAktiv, ikke rekrutterendeLevermetastaser | Metastatisk bugspytkirtelkræft | Gadoxetat-natrium-forstærket magnetisk resonansbilleddannelseJapan
-
AstraZenecaAfsluttetKarcinom, ikke-småcellet lungeJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Translational Research Center for Medical Innovation...The Jikei University School of MedicineAfsluttet
-
Asahi Kasei Pharma CorporationAfsluttetPostoperativ trin II/III tyktarmskræftJapan
-
Taiho Pharmaceutical Co., Ltd.Afsluttet
-
GAIA BioMedicine Inc.Rekruttering
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUkendtKræft i bugspytkirtlenJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUkendt
-
TakedaAktiv, ikke rekrutterendeHepatocellulær kræftJapan
-
Eastern Network of Cancer Immunological Therapy...Afsluttet
-
Eli Lilly and CompanyAfsluttetLymfom | Karcinom, ikke-småcellet lunge | Faste tumorerJapan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Wakayama Medical UniversityAfsluttetKræft i bugspytkirtlen | Galdevejskræft | Pancreatitis | Duodenal cancer | Ampulær kræftJapan
-
Osaka Medical Center for Cancer and Cardiovascular...AfsluttetKræft i bugspytkirtlenJapan
-
Japan Clinical Cancer Research OrganizationAfsluttet
-
Translational Research Center for Medical Innovation...Japanese Gynecologic Oncology Group (JGOG); Department of Obstetrics and... og andre samarbejdspartnereAfsluttetLivmoderhalskræft | Æggelederkræft | Primær peritoneal kræftJapan
-
PfizerAfsluttet
-
Osaka Medical Center for Cancer and Cardiovascular...AfsluttetKræft i bugspytkirtlenJapan
-
Fukushima Medical UniversityUkendtKræft i bugspytkirtlenJapan
-
AstraZenecaAfsluttetDel A og B: Avancerede solide maligniteter | Del C: Malignt mesotheliomJapan
-
Multicenter Clinical Study Group of Osaka, Colorectal...UkendtKolorektal cancerJapan
-
Hokkaido Gastrointestinal Cancer Study GroupHokkaido University HospitalAfsluttet
-
Hokkaido Gastrointestinal Cancer Study GroupHokkaido University HospitalAfsluttet
-
Hokkaido Gastrointestinal Cancer Study GroupAfsluttet
-
GlaxoSmithKlineAfsluttet
-
National Cancer Center Hospital EastMerck Sharp & Dohme LLCRekruttering
-
Hokkaido Gastrointestinal Cancer Study GroupSuspenderet
-
Iwate Medical UniversityUkendt
-
Kinki UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUkendt
-
Kyowa Kirin Co., Ltd.Afsluttet
-
TakedaRekruttering
-
Kazuhiko YoshimatsuHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttetKolorektal cancerJapan
-
Otsuka Pharmaceutical Co., Ltd.AfsluttetAkut myeloid leukæmi | Myelomatose | Non-Hodgkin lymfom | Kronisk myeloid leukæmi | Akut lymfoid leukæmiJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Kagawa UniversityAfsluttetMavekræft | KemoradiationJapan
-
TakedaAfsluttetMave-/duodenalsår, MALT-lymfom i mave, idiopatisk trombocytopenisk purpura eller H. Pylori gastritis og andetJapan
-
BayerAfsluttetKarcinom, nyrecelleJapan
-
Kyoto UniversityUkendtKolorektal cancer | LevermetastaseJapan
-
Osamu UkimuraRekruttering
-
Kyushu UniversityRekrutteringPædiatriske solide tumorer | Refraktær/tilbagefaldende neuroblastomJapan
-
TakedaAfsluttetRecidiverende og/eller refraktært myelomatoseJapan
-
Sumitomo Pharma Co., Ltd.Afsluttet
-
Chugai PharmaceuticalJapan Lung Cancer SocietyAfsluttetIkke-småcellet lungekræftJapan
-
Hokkaido Gastrointestinal Cancer Study GroupHokkaido University HospitalSuspenderetKræft i bugspytkirtlenJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttetKræft i bugspytkirtlenJapan
-
GlaxoSmithKlineAfsluttetLeukæmi, lymfoblastisk, akut og lymfom, lymfoblastiskJapan
-
AstraZenecaAfsluttetInoperabel lokalt avanceret eller metastatisk galdevejskræftJapan